Clinical trials
Phase 1 Overweight trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 7 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 11 |
| Zealand Pharma | 6 |
| Boehringer Ingelheim | 2 |
| University of Jena | 2 |
| Beta-Stim Ltd. | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| MEDIGREIF Inselklinik Heringsdorf | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 25 |
| Obesity | 22 |
| Diabetes Mellitus, Type 2 | 3 |
| Hypercholesterolemia | 2 |
| Body Weight | 1 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Endocrine System Diseases | 1 |
| Glucose Metabolism Disorders | 1 |
| Metabolic Diseases | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.